The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting
Digital Health Global
OCTOBER 23, 2023
Christopher Riley is a forward-thinking, financially astute finance and operation’s executive with talent for re-engineering, building, and profitably growing businesses to achieve significant shareholder value in medical technology and consumer product markets for multinational & entrepreneurial organizations.
88 
Let's personalize your content